Landmark Myopia Control Trial Receives Top Recognition
Wednesday, March 11 2026 | 11 h 55 min | Optik Magazine, Vision Science
At a Glance
- Six-year multicentre clinical trial on dual-focus soft contact lenses
- Demonstrated significant slowing of myopia progression and axial elongation
- Received the 2025 Garland W. Clay Award
- Research collaboration included University of Waterloo and CooperVision
Summary
A long-term randomized clinical trial evaluating dual-focus soft contact lenses for pediatric myopia control has been honoured with the Garland W. Clay Award for the most impactful paper published in Optometry and Vision Science over the past five years. The six-year data confirmed sustained reduction in myopia progression and axial length growth in children wearing dual-focus lenses compared to single-vision controls.
The findings further strengthen the evidence base supporting soft contact lenses as an effective, safe intervention in childhood myopia management.
Practice Considerations
With mounting long-term evidence, optometrists can confidently position dual-focus soft lenses as a primary myopia control strategy. The study reinforces the importance of early intervention and consistent follow-up, particularly as parental demand for evidence-based solutions continues to grow.
